Pharmaceutical Injection

Approx. Rs 1,003 / UnitGet Latest Price

Approx. Rs 160 / StripeGet Latest Price

Approx. Rs 350 / StripeGet Latest Price

Uses :

Hiforce 50 ODS (FOR EXPORT ONLY) from Healing Pharma a medication that is most regularly utilized and know for the treatment of erectile brokenness in male sexual capacity issues. The dynamic fixing in the medication is sildenafil citrate. It is commonly used to build blood stream to the penis to enable a man to get and support his erection to improve sexual movement.

Side Effects:

The basic symptoms happening in 2% or a greater amount of the patients experiencing treatment with Generic Sildenafil Oral Film incorporate migraine, flushing, dyspepsia, nasal clog, urinary tract disease, unusual vision, loose bowels, tipsiness and rash.

This is not a exhaustive list of side effects and others may occur.Please contact your doctor immediately if any of these symptoms are found.

Approx. Rs 774 / UnitGet Latest Price

• Penfill cartridges for use with Novo Nordisk insulin devices only. 
• Store between 2°C - 8°C in a refrigerator. 
• Do not freeze. Protect from light. 
• See package insert for Usage, Dosage and Storage. 
• Penfill'' cartridge is for use by one person only. 
• Keep out of the reach and sight of children. 
• During use, NovoRapid Penfill may be kept at room temperature below 30°C for up to 4 weeks. 
• Destroy Penfill after use. 
• Ask for NovoFine needles. 
• NovoRapid

Product Price :Get Latest Price

Product Price :Get Latest Price

Product Price :Get Latest Price

Product Price :Get Latest Price

Approx. Rs 400 / StripeGet Latest Price

Approx. Rs 8,900 / VialGet Latest Price

Approx. Rs 350 / BoxGet Latest Price

Approx. Rs 145 / StripeGet Latest Price

Product Price :Get Latest Price

Product Price :Get Latest Price

Product Price :Get Latest Price

Product Price :Get Latest Price

Product Price :Get Latest Price

Approx. Rs 200 / VialGet Latest Price

Approx. Rs 12,000 / PieceGet Latest Price

Approx. Rs 5,000 / PieceGet Latest Price

Discover the Power of 3 in the Ozempic® Tri-Zone

Lowering A1C is an important part of managing type 2 diabetes. But so is managing your potential risk of major cardiovascular (CV) events if you also have known heart disease, and also losing some weight. Ozempic®, along with diet and exercise, is proven to improve blood sugar in adults with type 2 diabetes. In adults with type 2 diabetes and known heart disease, Ozempic® reduces the risk of major cardiovascular events such as stroke, heart attack, or death.

Ozempic® provides powerful A1C reductiona

The American Diabetes Association (ADA) recommends that a reasonable goal for most adults with type 2 diabetes is an A1C less than 7%. Your health care provider will tell you what goal is right for you.

Ozempic (semaglutide) is a once-weekly injection used to improve blood sugar levels in adults with type 2 diabetes mellitus. Ozempic is also used to lower the risk of major cardiovascular events like stroke, heart attack or death, for adults with type 2 diabetes who also have heart disease. Ozempic should be used along with diet and exercise.

Ozempic should not be used for type 1 diabetes mellitus. Ozempic is not FDA approved for weight loss.

Ozempic is from a class of medicines called a glucagon-like peptide-1 (GLP-1) agonists (incretin mimetics).

Ozempic works by binding to GLP-1 receptors which stimulates insulin release from the pancreas when you need insulin, it also helps to reduce the amount of sugar released by your liver and slows down food leaving your stomach. The combination of these effects helps to lower your A1C and blood sugar levels, and may also help reduce your appetite.

Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

You should not use this medicine if you have multiple endocrine neoplasia type 2 (tumors in your glands), or a personal or family history of medullary thyroid cancer.

You should not use this medicine if you are allergic to semaglutide or any other ingredients in this medicine, or if you have:

• multiple endocrine neoplasia type 2 (tumors in your glands); or
• a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer).

To make sure this medicine is safe for you, tell your doctor if you have ever had:

• a stomach or intestinal disorder;
• pancreatitis;
• kidney disease; or
• eye problems caused by diabetes (retinopathy).

In animal studies, this medicine caused thyroid tumors or thyroid cancer. It is not known whether these effects would occur in people. Ask your doctor about your risk.

Additional Information:

Approx. Rs 5,000 / PieceGet Latest Price

Discover the Power of 3 in the Ozempic® Tri-Zone

Lowering A1C is an important part of managing type 2 diabetes. But so is managing your potential risk of major cardiovascular (CV) events if you also have known heart disease, and also losing some weight. Ozempic®, along with diet and exercise, is proven to improve blood sugar in adults with type 2 diabetes. In adults with type 2 diabetes and known heart disease, Ozempic® reduces the risk of major cardiovascular events such as stroke, heart attack, or death.

Ozempic® provides powerful A1C reductiona

The American Diabetes Association (ADA) recommends that a reasonable goal for most adults with type 2 diabetes is an A1C less than 7%. Your health care provider will tell you what goal is right for you.

Ozempic (semaglutide) is a once-weekly injection used to improve blood sugar levels in adults with type 2 diabetes mellitus. Ozempic is also used to lower the risk of major cardiovascular events like stroke, heart attack or death, for adults with type 2 diabetes who also have heart disease. Ozempic should be used along with diet and exercise.

Ozempic should not be used for type 1 diabetes mellitus. Ozempic is not FDA approved for weight loss.

Ozempic is from a class of medicines called a glucagon-like peptide-1 (GLP-1) agonists (incretin mimetics).

Ozempic works by binding to GLP-1 receptors which stimulates insulin release from the pancreas when you need insulin, it also helps to reduce the amount of sugar released by your liver and slows down food leaving your stomach. The combination of these effects helps to lower your A1C and blood sugar levels, and may also help reduce your appetite.

Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

You should not use this medicine if you have multiple endocrine neoplasia type 2 (tumors in your glands), or a personal or family history of medullary thyroid cancer.

You should not use this medicine if you are allergic to semaglutide or any other ingredients in this medicine, or if you have:

• multiple endocrine neoplasia type 2 (tumors in your glands); or
• a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer).

To make sure this medicine is safe for you, tell your doctor if you have ever had:

• a stomach or intestinal disorder;
• pancreatitis;
• kidney disease; or
• eye problems caused by diabetes (retinopathy).

In animal studies, this medicine caused thyroid tumors or thyroid cancer. It is not known whether these effects would occur in people. Ask your doctor about your risk.

Additional Information:

Approx. Rs 5,000 / BoxGet Latest Price

What Is Wegovy?

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

What Are Side Effects of Wegovy?

Wegovy may cause serious side effects including:

hives, difficulty breathing, swelling of your face, lips, tongue, or throat, sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, seeing halos around lights, fast, irregular, or pounding heartbeats, fluttering in your chest, shortness of breath, sudden dizziness, lightheadedness, fainting, severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff or rigid muscles, high fever, profuse sweating, and tremors

Get medical help right away, if you have any of the symptoms listed above.

Side effects of Wegovy include:

nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion/heartburn, dizziness, bloating (abdominal distension), belching, low blood sugar (hypoglycemia) in patients with type 2 diabetes, gas (flatulence), gastroenteritis, and gastroesophageal reflux disease (GERD).

Seek medical care or call 911 at once if you have the following serious side effects:

Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;

Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheadedness, or passing out;

Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

Dosage for Wegovy

The initial dose of Wegovy is 0.25 mg once weekly for 4 weeks. In 4-week intervals, increase the dose until a dose of 2.4 mg is reached. The maintenance dose of Wegovy is 2.4 mg once weekly, administered on the same day each week, at any time of day, with or without meals.

Wegovy In Children

Safety and efficacy of Wegovy have not been established in pediatric patients.

Wegovy may interact with other medicines such as:

insulin secretagogues (e.g., sulfonylureas) or insulin and

other oral medications taken at the same time.

Tell your doctor all medications and supplements you use.

Dosage

The dose starts low and escalates to minimize gastrointestinal side effects.

Initial Dose Escalation Schedule for patients aged 12 years and older:

•             Weeks 1 through 4 (month one): 0.25 mg subcutaneously once a week

•             Weeks 5 through 8 (month two): 0.5 mg subcutaneously once a week

•             Weeks 9 through 12 (month three): 1 mg subcutaneously once a week

•             Weeks 13 through 16 (month four): 1.7 mg subcutaneously once a week

Maintenance Dose:

•             Week 17 and onward: 2.4 mg subcutaneously once a week. See additional notes below about maintenance dosing.

Additional Information:

Approx. Rs 5,000 / VialGet Latest Price

Additional Information:

Approx. Rs 5,000 / PieceGet Latest Price

Discover the Power of 3 in the Ozempic® Tri-Zone

Lowering A1C is an important part of managing type 2 diabetes. But so is managing your potential risk of major cardiovascular (CV) events if you also have known heart disease, and also losing some weight. Ozempic®, along with diet and exercise, is proven to improve blood sugar in adults with type 2 diabetes. In adults with type 2 diabetes and known heart disease, Ozempic® reduces the risk of major cardiovascular events such as stroke, heart attack, or death.

Ozempic® provides powerful A1C reductiona

The American Diabetes Association (ADA) recommends that a reasonable goal for most adults with type 2 diabetes is an A1C less than 7%. Your health care provider will tell you what goal is right for you.

Ozempic (semaglutide) is a once-weekly injection used to improve blood sugar levels in adults with type 2 diabetes mellitus. Ozempic is also used to lower the risk of major cardiovascular events like stroke, heart attack or death, for adults with type 2 diabetes who also have heart disease. Ozempic should be used along with diet and exercise.

Ozempic should not be used for type 1 diabetes mellitus. Ozempic is not FDA approved for weight loss.

Ozempic is from a class of medicines called a glucagon-like peptide-1 (GLP-1) agonists (incretin mimetics).

Ozempic works by binding to GLP-1 receptors which stimulates insulin release from the pancreas when you need insulin, it also helps to reduce the amount of sugar released by your liver and slows down food leaving your stomach. The combination of these effects helps to lower your A1C and blood sugar levels, and may also help reduce your appetite.

Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

You should not use this medicine if you have multiple endocrine neoplasia type 2 (tumors in your glands), or a personal or family history of medullary thyroid cancer.

You should not use this medicine if you are allergic to semaglutide or any other ingredients in this medicine, or if you have:

• multiple endocrine neoplasia type 2 (tumors in your glands); or
• a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer).

To make sure this medicine is safe for you, tell your doctor if you have ever had:

• a stomach or intestinal disorder;
• pancreatitis;
• kidney disease; or
• eye problems caused by diabetes (retinopathy).

In animal studies, this medicine caused thyroid tumors or thyroid cancer. It is not known whether these effects would occur in people. Ask your doctor about your risk.

Additional Information:

Approx. Rs 5,000 / BoxGet Latest Price

What Is Wegovy?

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

What Are Side Effects of Wegovy?

Wegovy may cause serious side effects including:

hives, difficulty breathing, swelling of your face, lips, tongue, or throat, sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, seeing halos around lights, fast, irregular, or pounding heartbeats, fluttering in your chest, shortness of breath, sudden dizziness, lightheadedness, fainting, severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff or rigid muscles, high fever, profuse sweating, and tremors

Get medical help right away, if you have any of the symptoms listed above.

Side effects of Wegovy include:

nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion/heartburn, dizziness, bloating (abdominal distension), belching, low blood sugar (hypoglycemia) in patients with type 2 diabetes, gas (flatulence), gastroenteritis, and gastroesophageal reflux disease (GERD).

Seek medical care or call 911 at once if you have the following serious side effects:

Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;

Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheadedness, or passing out;

Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

Dosage for Wegovy

The initial dose of Wegovy is 0.25 mg once weekly for 4 weeks. In 4-week intervals, increase the dose until a dose of 2.4 mg is reached. The maintenance dose of Wegovy is 2.4 mg once weekly, administered on the same day each week, at any time of day, with or without meals.

Wegovy In Children

Safety and efficacy of Wegovy have not been established in pediatric patients.

Wegovy may interact with other medicines such as:

insulin secretagogues (e.g., sulfonylureas) or insulin and

other oral medications taken at the same time.

Tell your doctor all medications and supplements you use.

Dosage

The dose starts low and escalates to minimize gastrointestinal side effects.

Initial Dose Escalation Schedule for patients aged 12 years and older:

•             Weeks 1 through 4 (month one): 0.25 mg subcutaneously once a week

•             Weeks 5 through 8 (month two): 0.5 mg subcutaneously once a week

•             Weeks 9 through 12 (month three): 1 mg subcutaneously once a week

•             Weeks 13 through 16 (month four): 1.7 mg subcutaneously once a week

Maintenance Dose:

•             Week 17 and onward: 2.4 mg subcutaneously once a week. See additional notes below about maintenance dosing.

Additional Information:

Approx. Rs 5,000 / BoxGet Latest Price

What Is Wegovy?

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

What Are Side Effects of Wegovy?

Wegovy may cause serious side effects including:

hives, difficulty breathing, swelling of your face, lips, tongue, or throat, sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, seeing halos around lights, fast, irregular, or pounding heartbeats, fluttering in your chest, shortness of breath, sudden dizziness, lightheadedness, fainting, severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff or rigid muscles, high fever, profuse sweating, and tremors

Get medical help right away, if you have any of the symptoms listed above.

Side effects of Wegovy include:

nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion/heartburn, dizziness, bloating (abdominal distension), belching, low blood sugar (hypoglycemia) in patients with type 2 diabetes, gas (flatulence), gastroenteritis, and gastroesophageal reflux disease (GERD).

Seek medical care or call 911 at once if you have the following serious side effects:

Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;

Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheadedness, or passing out;

Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

Dosage for Wegovy

The initial dose of Wegovy is 0.25 mg once weekly for 4 weeks. In 4-week intervals, increase the dose until a dose of 2.4 mg is reached. The maintenance dose of Wegovy is 2.4 mg once weekly, administered on the same day each week, at any time of day, with or without meals.

Wegovy In Children

Safety and efficacy of Wegovy have not been established in pediatric patients.

Wegovy may interact with other medicines such as:

insulin secretagogues (e.g., sulfonylureas) or insulin and

other oral medications taken at the same time.

Tell your doctor all medications and supplements you use.

Dosage

The dose starts low and escalates to minimize gastrointestinal side effects.

Initial Dose Escalation Schedule for patients aged 12 years and older:

•             Weeks 1 through 4 (month one): 0.25 mg subcutaneously once a week

•             Weeks 5 through 8 (month two): 0.5 mg subcutaneously once a week

•             Weeks 9 through 12 (month three): 1 mg subcutaneously once a week

•             Weeks 13 through 16 (month four): 1.7 mg subcutaneously once a week

Maintenance Dose:

•             Week 17 and onward: 2.4 mg subcutaneously once a week. See additional notes below about maintenance dosing.

Additional Information: